104 related articles for article (PubMed ID: 21737664)
41. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
42. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
43. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
Malaisrie SC; Hofstetter WL; Correa AM; Ajani JA; Komaki RR; Rice DC; Vaporciyan AA; Walsh GL; Roth JA; Wu TT; Swisher SG
Cancer; 2006 Sep; 107(5):967-74. PubMed ID: 16874819
[TBL] [Abstract][Full Text] [Related]
44. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
[TBL] [Abstract][Full Text] [Related]
45. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
46. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas.
Griffiths EA; Pritchard SA; Valentine HR; Whitchelo N; Bishop PW; Ebert MP; Price PM; Welch IM; West CM
Br J Cancer; 2007 Jan; 96(1):95-103. PubMed ID: 17179985
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.
Chiba I; Ogawa K; Morioka T; Shimoji H; Sunagawa N; Iraha S; Nishimaki T; Yoshimi N; Murayama S
Oncol Lett; 2011 Jan; 2(1):21-28. PubMed ID: 22870123
[TBL] [Abstract][Full Text] [Related]
48. Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1alpha in rectal cancer.
Korkeila E; Jaakkola PM; Syrjänen K; Sundström J; Pyrhönen S
Scand J Gastroenterol; 2010 Mar; 45(3):340-8. PubMed ID: 20001759
[TBL] [Abstract][Full Text] [Related]
49. Bronchoscopic finding determined outcome after chemoradiotherapy in esophageal cancer patients with airway invasion.
Yin SY; Chao YK; Tseng CK; Chang HK; Liu YH; Wu YC; Chen TP; Yeh CH
J Surg Oncol; 2014 Jun; 109(8):808-11. PubMed ID: 24578225
[TBL] [Abstract][Full Text] [Related]
50. Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer.
Havelund BM; Sørensen FB; Pløen J; Lindebjerg J; Spindler KL; Jakobsen A
APMIS; 2013 Feb; 121(2):127-38. PubMed ID: 23030583
[TBL] [Abstract][Full Text] [Related]
51. [A case of advanced esophageal cancer patient surviving more than 7 years treated with chemoradiotherapy].
Kubo N; Kawasaki H; Takahashi K; Maruyama M; Miyamoto K; Wajima N; Hakamada K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2385-7. PubMed ID: 22202390
[TBL] [Abstract][Full Text] [Related]
52. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
Chen Y; Wang CM; Shi YQ; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
[TBL] [Abstract][Full Text] [Related]
53. Clinical significance of CD133 and hypoxia inducible factor-1α gene expression in rectal cancer after preoperative chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Koike Y; Fujikawa H; Inoue Y; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):323-32. PubMed ID: 20970309
[TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.
Fraunholz I; Rödel F; Kohler D; Diallo-Georgiopoulou M; Distel L; Falk S; Rödel C
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):901-7. PubMed ID: 23755922
[TBL] [Abstract][Full Text] [Related]
55. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy.
Sauter ER; Coia LR; Eisenberg BL; Hanks GE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):567-9. PubMed ID: 7852121
[TBL] [Abstract][Full Text] [Related]
57. [A case of lung metastasis from esophageal cancer resistant to fluorouracil and cisplatin combination therapy but responsive to radiation therapy].
Ami K; Seki R; Takasaki J; Amagasa H; Kamikozuru H; Ganno H; Kurokawa T; Fukuda A; Nagahama T; Ando M; Yamada Y; Kodaka F; Arai K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2104-6. PubMed ID: 23267991
[TBL] [Abstract][Full Text] [Related]
58. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.
Muro K; Ohtsu A; Boku N; Chin K; Oda Y; Fujii T; Hosokawa K; Yoshida S; Hasebe T
Jpn J Clin Oncol; 1996 Apr; 26(2):65-9. PubMed ID: 8609696
[TBL] [Abstract][Full Text] [Related]
59. HIF-1α Levels in patients receiving chemoradiotherapy for locally advanced non-small cell lung carcinoma.
Afsar CU; Uysal P
Rev Assoc Med Bras (1992); 2019; 65(10):1295-1299. PubMed ID: 31721962
[TBL] [Abstract][Full Text] [Related]
60. CD133(+)HIF-1α(-) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer.
Tachikawa Y; Kawai K; Ozaki K; Nozawa H; Sasaki K; Murono K; Emoto S; Kishikawa J; Yokoyama Y; Abe S; Nagai Y; Anzai H; Sonoda H; Ishihara S
Anticancer Res; 2022 Apr; 42(4):2033-2043. PubMed ID: 35347026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
